Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review

Platinum-based chemotherapy has been the standard of care for ovarian cancer for the past 3 decades. Although most patients respond to platinum-based treatment, emergence of platinum resistance in recurrent ovarian cancer is inevitable during the disease course. Outcomes for patients with platinum-r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JAMA oncology Jg. 9; H. 6; S. 851
Hauptverfasser:	Richardson, Debra L, Eskander, Ramez N, O'Malley, David M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.06.2023
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - therapeutic use Carcinoma, Ovarian Epithelial - drug therapy Female Humans Neoplasm Recurrence, Local - drug therapy Ovarian Neoplasms - drug therapy Platinum - therapeutic use
ISSN:	2374-2445, 2374-2445
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!